Form D · Pharmaceuticals
Transport Pharmaceuticals Inc
Framingham, MA · CIK 0001308275
Offering snapshot reported Oct 6, 2009 · SEC filing
- Reported sold
- $99K Offering amount: $99K
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 23, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 6, 2009 | Initial | $99,000 | No comparison | 12 | SEC filing |
| Aug 20, 2009 | Initial | $200,000 | No comparison | 12 | SEC filing |
| Jul 9, 2009 | Initial | $500,000 | No comparison | 12 | SEC filing |
| Apr 22, 2009 | Initial | $1,000,000 | No comparison | Not reported | SEC filing |
| Feb 25, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Sep 22, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 16, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 14, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 31, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-70896
Source: Form D, filed Oct 6, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Russell W. Ayres, Iii | Director |
| Brian Gallagher | Director |
| Dennis I. Goldberg | Director, Executive |
| Charles G. Hadley | Director |
| Richard S. Kollender | Director |
| Ryan M. Schwarz | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
161 Worcester Road Suite 402
Framingham, MA, 01701
Framingham, MA, 01701